— Know what they know.
Not Investment Advice
Also trades as: IHL.AX (ASX) · $vol 0M

IXHL NASDAQ

Incannex Healthcare Limited
1W: -3.3% 1M: -1.8% 3M: -19.6% YTD: -72.6% 1Y: -75.2% 3Y: -97.8%
$3.21
-0.04 (-1.23%)
 
Weekly Expected Move ±8.6%
$3 $3 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $38.4M mcap · 10M float · 1.97% daily turnover · Short 28% of daily vol

Cash Flow Trends

Operating Cash Flow
-$13M -2.8% ▼
Capital Expenditures
$10K -25.0% ▼
5Y CAGR: +402.8%
Free Cash Flow
-$13M -2.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$53M +473.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income-$10M-$49M-$18M-$47M-$19M
Depreciation & Amort.$0$88K$103K$246K$240K
Stock-Based Comp.$1M$2M$9M$3M$8M
Change in Working Capital$80K-$626K-$9M$7M$0
Other Non-Cash Items$319K$36M$3M$25M-$1M
Operating Cash Flow-$9M-$11M-$16M-$13M-$13M
— Investing Activities —
Capital Expenditures$0-$316K-$277K-$8K-$10K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0-$84K
Investing Cash Flow$0-$316K-$277K-$8K-$94K
— Financing Activities —
Net Debt Issuance$0-$36K$0-$1M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$2M$36K$0-$25M$66M
Financing Cash Flow$28M$8M$0$21M$66M
Net Change in Cash$20M-$4M-$16M$9M$53M
Cash End of Period$26M$22M$6M$15M$68M
Free Cash Flow-$9M-$11M-$16M-$13M-$13M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms